# Plain Language Summary: Uterine Fibroids Awareness Month

This bill is a simple designation that officially recognizes July 2022 as "Uterine Fibroids Awareness Month" at the federal level. It's the kind of resolution Congress passes to draw attention to specific health conditions and encourage public awareness.

Uterine fibroids are noncancerous tumors that grow in or around the uterus and affect millions of women, particularly Black women who experience them at higher rates and often with more severe symptoms. By designating a specific month for awareness, the bill aims to encourage conversations about this common condition, promote education about treatment options, and highlight the experiences of people living with fibroids.

In practical terms, this designation doesn't create new laws, funding, or requirements. Instead, it's a symbolic action that encourages health organizations, medical professionals, and the public to use July as a time to share information about fibroids, their symptoms, and available treatments. It might lead to more media coverage, educational campaigns, or community events focused on the condition during that month. For people with fibroids or those at risk, increased awareness can help them recognize symptoms earlier and seek appropriate medical care. The bill essentially says: "This matters, and we want people to know about it."

Supporting the designation of July 2022 as Uterine Fibroids Awareness Month.

Scott, David

 <p>This resolution expresses support for the goals and ideals of Uterine Fibroids Awareness Month. Uterine fibroids are muscular tumors that grow in the wall of the uterus and may cause pain, heavy menstrual bleeding, and reproductive issues.</p>